Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) Equity Ratio: 2011-2025

Historic Equity Ratio for Mimedx Group (MDXG) over the last 14 years, with Sep 2025 value amounting to 0.75.

  • Mimedx Group's Equity Ratio rose 0.93% to 0.75 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.75, marking a year-over-year increase of 0.93%. This contributed to the annual value of 0.73 for FY2024, which is 22.56% up from last year.
  • As of Q3 2025, Mimedx Group's Equity Ratio stood at 0.75, which was up 0.66% from 0.74 recorded in Q2 2025.
  • Mimedx Group's Equity Ratio's 5-year high stood at 0.75 during Q1 2025, with a 5-year trough of -0.11 in Q3 2022.
  • Moreover, its 3-year median value for Equity Ratio was 0.73 (2024), whereas its average is 0.51.
  • Per our database at Business Quant, Mimedx Group's Equity Ratio crashed by 24,147.84% in 2022 and then soared by 10,447.82% in 2024.
  • Mimedx Group's Equity Ratio (Quarterly) stood at 0.00 in 2021, then slumped by 24,147.84% to -0.10 in 2022, then surged by 668.98% to 0.60 in 2023, then grew by 22.56% to 0.73 in 2024, then climbed by 0.93% to 0.75 in 2025.
  • Its Equity Ratio was 0.75 in Q3 2025, compared to 0.74 in Q2 2025 and 0.75 in Q1 2025.